In order to insure public health and safety, a reliable screening analysis is necessary to determine veterinary drug residue levels in milk samples. The compounds of interest range from highly polar water-soluble compounds to very non-polar fat-soluble compounds. There exists very effective extraction and cleanup procedures for individual compounds or compound classes, but these methods are not well suited for a multi-class, multi-residue screening analysis.
Optimized sample preparation and analysis protocols were developed for tandem LC-MS/MS determination of a wide variety of veterinary drug residues in milk samples. Samples are initially precipitated and extracted with an equal volume of acetonitrile. After the resulting extract is treated with acidified acetonitrile to precipitate remaining proteins, a simple SPE cleanup is performed using a Sep-Pak C18 cartridge. After evaporation and reconstitution, the sample is analyzed using tandem LC-MS. Representative compounds were chosen from major classes of veterinary drugs including tetracyclines, fluoroquinolones, sulfonamides, macrolides, beta-lactams, NSAIDS, steroids, and beta-andrenergids.
LC system: |
ACQUITY UPLC system |
Column: |
ACQUITY UPLC CSH C18, 1.7 μm, 100 mm x 2.1 mm (i.d.) |
Mobile phase A: |
0.1% formic in water |
Mobile phase B: |
0.1% formic acid acetonitrile |
Injection volume: |
7 μL |
Injection mode: |
Partial loop injection |
Column temperature: |
30 °C |
Weak needle wash: |
10:90 acetonitrile:water (600 μL) |
Strong needle wash: |
50:30:20 water:acetonitrile:IPA (200 μL) |
Seal wash: |
10:90 acetonitrile:water |
Time(min) |
Flow(mL/min) |
%A |
%B |
Curve |
---|---|---|---|---|
Initial |
0.4 |
85 |
15 |
6 |
2.5 |
0.4 |
60 |
40 |
6 |
3.9 |
0.4 |
5 |
95 |
6 |
4.9 |
0.4 |
5 |
95 |
6 |
5.0 |
0.4 |
85 |
15 |
6 |
7.0 |
0.4 |
85 |
15 |
6 |
Mass spectrometer: |
Waters ACQUITY TQD |
Source temperature: |
150 °C |
Desolvation temperature: |
500 °C |
Desolvation gas flow: |
1000 L/Hr |
Cone gas flow: |
30 L/Hr |
Collision gas flow: |
0.15 mL/min |
Data management: |
MassLynx v4.1 |
Table 1 summarizes the MRM transitions and instrument parameters used for this study. Also presented in Table 1 are matrix-matched calibration data for each compound (calculated using the primary transition).
Figure 2 shows a typical LC-MS chromatogram obtained from analysis of a matrix matched standard of erythromycin at 6.7 ng/g. Performance of the other compounds was similar. Table 2 shows the recovery and matrix effects observed for multiresidue milk analysis.
Table 2. Recovery and matrix effects.
* Negative number signifies matrix enhancement
The procedure chosen for the milk analysis was to initially extract and precipitate a milk sample with an equivalent amount of acetonitrile and then to precipitate the remaining protein from the supernatant with acidified acetonitrile. A single step procedure was also considered by which the milk sample was directly precipitated with 0.2% formic acid in 80% acetontrile. This procedure was more straightforward and produced a final extract of similar cleanliness compared with the chosen protocol. However, there was significantly lower recovery for the most polar compounds, such as sulfanilamide, and virtually no recovery of chlorotetracycline. Another approach was considered, by which two separate extractions were performed. The first extraction, for the water soluble compounds, was accomplished using aqueous succinic buffer. The second, performed on the re-suspended pellet, was with acetonitrile. This approach requires that each fraction be worked up independently before ultimately combining fractions for a single injection. Performance was marginally better than the chosen procedure but at a much greater cost of time and materials. Although the chosen procedure requires two precipitation steps, it provided the best balance of preparative time with good method performance.
The procedure was suitable for screening for a wide range of veterinary drug residues
Recoveries averaged 67% (22-110) with the lowest values for tetracyclines.
720004089, August 2011